Get all your news in one place.
100's of premium titles.
One app.
Start reading
The National (Scotland)
The National (Scotland)
National
Jane McLeod

HISTORICAL FACTS: Scottish technology that could transform cancer testing handed millions | History Defined

Kerry Sharp is director of entrepreneurship and investment at Scottish Enterprise

A SCOTTISH medical technology company has announced £2.1 million additional seed financing – in an oversubscribed funding round – to complete its first human trials.

Based on research from Edinburgh University professors Tim Aitman and Mark Bradley, Biocaptiva have developed BioCaptis, a device slated to “transform liquid biopsy testing”, which is a type of blood test commonly used in the diagnosis and management of cancer.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.